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WHAT THIS PAPER ADDS
 Prosthetic patch infection following carotid endarterectomy is a rare but feared complication. Although covered stents have
emerged as an alternative treatment strategy, there is limited long term data regarding late reinfection. For now, patch excision and
autologous reconstruction remains the ‘gold standard’ and can be performed with low rates of reinfection. Revascularisation with
prosthetic material should be avoided.a r t i c l e i n f o
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Objectives: Outcomes following prosthetic patch infection after carotid endarterectomy (CEA).
Methods: Retrospective audit and systematic review.
Results: 22 patients were treated between January 1992 and April 2012, 5 having undergone their original
CEA at another institution. The commonest infecting organism was Staphylococcus. One patient was
treated by antibiotic irrigation, one was stented, while 20 underwent debridement and patch excision
plus; carotid ligation (n ¼ 3), vein patching (n ¼ 3) or vein bypass (n ¼ 14). There was one peri-operative
stroke, but no peri-operative deaths. There were no reinfections at a median follow-up of 54 months.
A systematic review identiﬁed 123 patients with prosthetic patch infection in the world literature.
Thirty-six (29%) presented <2 months, 78 (63%) presented >6 months after the original CEA. Seventy-
nine of/87 patients (91%) with a positive culture yielded Staphylococci or Streptococci. Seventy-four
patients were treated by patch excision and autologous reconstruction. Four (5%) developed reinfec-
tion <30 days, but later reinfections have been reported. Seven of nine patients (78%) undergoing
prosthetic reconstruction either died or suffered reinfection. Five patients were treated with a covered
stent, none developing reinfection (median followup 12 months).
Conclusion: Patch infection following CEA is rare. Few have undergone stenting and long term data are
awaited. For now, patch excision and autologous reconstruction remains the ‘gold standard’.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Randomised trials have demonstrated that carotid endarterec-
tomy (CEA) has a proven role in selected patients with symptomatic
and asymptomatic carotid disease.1e4 During traditional CEA, the
arteriotomy can be closed primarily or be selectively/routinely
patched. No randomised trials have compared routine with selec-
tive patching, but randomised trials have shown that a policy ofann).
ciety for Vascular Surgery. Publishroutine patch closure (compared with routine primary closure) is
associated with signiﬁcant reductions in peri-operative stroke,
early thrombosis, late restenosis and late stroke.5,6 In systematic
reviews, synthetic patches (PTFE, Dacron) conferred similar short
and long-term beneﬁts (compared with autologous vein) and offer
the added beneﬁts of being readily available, they avoid groin
incisions, they preserve the long saphenous vein for future coro-
nary or peripheral vascular reconstructions and have a lower inci-
dence of early patch rupture.7e9 However, and in common with
vascular reconstructions elsewhere in the body, the main disad-
vantage with using prosthetic material is the risk of infection.
Interestingly, while everyone has heard of prosthetic patched by Elsevier Ltd. All rights reserved.
Figure 1. Using the ‘high approach’ to the upper carotid region,42 the infected patch
has been partially exposed but the distal ICA is enclosed in ﬁbrous tissue. A shunt has
been inserted through the exposed segment of patch and a Fogarty catheter controls
the ECA origin. The shunt enables the surgeon to know where the distal ICA runs and
enables more controlled distal exposure with no risk of major haemorrhage. A segment
of reversed vein has been placed over the distal limb of the Pruitt shunt so that an
interposition bypass can be performed without having to remove the shunt at a later
time.
C.D. Mann et al. / European Journal of Vascular and Endovascular Surgery 44 (2012) 20e26 21infection, after CEA, fewer than 80 cases had been reported in the
world literature prior to the current report.10
The aim of this audit was to establish the prevalence, presen-
tation, management and outcome of prosthetic patch infection in
a large single-centre series, supplemented by a systematic review
of the literature which identiﬁed 123 patients who have been
treated for prosthetic patch infection.10e38
Materials and Methods
Between 1st January 1992 and 1st April 2012, 2215 patients
underwent CEA in the Vascular Unit at the Leicester Royal Inﬁr-
mary. Of these,198 (8.9%) underwent vein patch closure (during the
ﬁrst half of the study period) and have been excluded from anal-
yses, leaving 2017 patients who underwent prosthetic patch
closure (Polyester ¼ 2012, PTFE ¼ 5). The Leicestershire, North-
amptonshire and Rutland Research Ethics Committee advised that
this study did not fall under the remit of the NHS Research Ethics
Committee as it was audit/service evaluation. Eight of the 22
patients were included in an earlier report of patch infection pub-
lished in 2002.39
Primary operative technique
All 2017 patients underwent CEA under normocarbic, normo-
thermic general anaesthesia, using systemic heparinisation, intra-
venous prophylactic antibiotics, routine shunting, routine tacking
and routine prosthetic patching. Between 1992 and 1995, three
doses of intravenous Co-Amoxiclav (1.2 g) were administered for
antibiotic prophylaxis starting immediately prior to induction of
anaesthesia and 8 hourly thereafter. This policy changed to three
doses of intravenous Cefuroxime (750 mg) and Metronidazole
(500mg) between 1995 and 2009, but reverted back to intravenous
Co-Amoxiclav from 2010 to the current date. There is no evidence
that changes in antibiotic prophylaxis inﬂuenced the incidence of
patch infections. All patients with an accessible temporal window
underwent routine intra-operative transcranial Doppler (TCD)
monitoring of blood ﬂow velocity in the middle cerebral artery
(MCA) and completion angioscopy.
Post-operative care after original CEA
Patients were monitored in theatre recovery for 3e6 h. In an
attempt to minimise early neck haematoma formation (which
might predispose towards early wound infection), blood pressure
was carefully monitored, although it was not until 2008 that
written guidance on managing post CEA hypertension was
provided.40 Anyone with a clinical wound infection was treated
with oral or intravenous antibiotics as appropriate. The majority of
patients were discharged on day 3. Patients were reviewed in the
outpatient clinic at 6 weeks and thereafter discharged with
instructions to return if any new symptoms or wound complica-
tions developed. This audit therefore, only includes patients in
whom a diagnosis of patch infection was suspected and who were
then referred to the Vascular Unit for treatment. It is accepted that
a small but indeterminate number may have suffered a late patch
infection and not have been referred back.
Principles of managing carotid patch infections
Where ever possible, patients with suspected patch infection
had routine bloods (haematology/biochemistry) and blood cultures
taken, as well as microbiological swabs from any discharging
wounds. All patients were started on parenteral antibiotics
(Cephalosporin and Metronidazole until 2002, Co-amoxiclavthereafter), revised once cultures/sensitivities were available and
continued for 6 weeks following surgery or until there was no
clinical evidence of infection. Intravenous Vancomycin was used in
cases of early infection (<60 days) to cover against MRSA. Where
possible, surgery was delayed until cultures were available. Our
policy was to perform Duplex ultrasound (unless contraindicated
bymassive haemorrhage) in order to exclude false aneurysm and to
establish the patency of the internal (ICA), external (ECA) and
common carotid arteries (CCA), as well as patch corrugation which
has been recognised as a warning sign of patch infection.41 In
addition, CT angiography was increasingly performed during the 20
year audit period in order to evaluate the status and/or accessibility
of the upper limits of the ICA. CT imaging was always performed in
any patient inwhom there was any question of having to access the
distal ICA near the skullbase.
The operative technique was similar in most cases. Nineteen
procedures were performed with intra-operative TCD monitoring.
TCD monitoring was not available for the three emergency opera-
tions associated with patch rupture which took place either at
weekends or out of hours during week days. The ﬁrst step was to
control the proximal CCA immediately above the clavicle. The
original incisionwas then reopened preserving the hypoglossal and
vagus nerves and the distal ICA exposed. On a practical note, it is
not unusual to encounter considerable ﬁbrosis around the upper
limits of the original reconstruction. This increases the risk of
inadvertent haemorrhage and cranial nerve injury. Accordingly, it is
now our practice to insert a Pruitt Inahara shunt as soon as possible
(proximal CCA clamp, shunt inserted through the partially exposed
patch before distal dissection and exposure of the upper ICA is
completed). An inﬂated Fogarty balloon catheter controls the ECA
(Fig. 1). The presence of a functioning shunt ensures adequate brain
perfusion, but more importantly it permits easier distal exposure
because the shunt is now palpable (thus identifying the ICA in any
ﬁbrous tissue) and because the risk of sudden haemorrhage
following any breach in the arterial wall is avoided. In these situ-
ations, we would normally position a segment of reversed saphe-
nous vein over the distal limb of the Pruitt shunt prior to insertion
so that a bypass can then be performed without shunt removal.
Where ever possible, arterial reconstruction (vein patch, vein
bypass) was performed after complete debridement of infected
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occluded pre-operatively. Ligation was performed in cases of ICA
occlusion and very occasionally in patients with a known MRSA
infection provided good collateral ﬂow had been demonstrated on
TCD at the original operation (mean MCAV >20 cm/s). If pre-
operative investigations suggested that access to the upper ICA
might be challenging, a combined procedure was undertaken with
an Ear Nose and Throat Surgeon using an operative technique
permitting access to the skullbase which has been described else-
where.42 All wounds were closed over suction drains. Gentamicin-
impregnated sponges (Gentacoll/Collatamp G, Schering-Plough
Ltd, Denmark) were placed around the reconstruction and debri-
ded tissues to optimise eradication of infection.
Literature review
A systematic literature review was undertaken of patients with
prosthetic patch infection following CEA up to 25th August 2011.
Studies were identiﬁed by manual journal reviews (European
Journal of Vascular and Endovascular Surgery, Journal of Vascular
Surgery, Annals of Vascular Surgery), cross-referencing, and an
electronic PUBMED search, using the search terms ‘patch infection’,
prosthetic infection, ‘carotid pseudoaneurysm’. Patients with sus-
pected patch infection following vein patch angioplasty or after
biological patching (eg bovine pericardium) were excluded from
this review, as were reports of patients treated for pseudo-
aneurysms with no suspicion of infection or following primary
closure. Thirty-three eligible studies were identiﬁed following
a detailed literature review.10e38,43e46 Four were subsequently
excluded due to an inability to extract individual patient data and
outcomes,43e46 while the current paper supercedes an earlier
study39 The remaining 29 series (101 patients) were included in the
systematic review,10e38 along with the 22 patients from the current
study. Cumulative analyses were performed using the
KaplaneMeier method on SPSS.
Results
Between January 1992 and 1st April 2012, 17/2017 patients
(0.8%) undergoing their primary CEA at the Leicester Royal Inﬁr-
mary with prosthetic patching were subsequently treated for patchTable 1
Presentation and management of carotid patch infections.
Case Post-operative wound problem Presentation Interval Prim
1 Wound infection Abscess 10 days Ligat
2 Wound infection Abscess 13 days V. pa
3 Abscess Abscess 16 days Anti
4 Wound infection Patch rupture 24 days V. by
5 Wound infection Abscess 27 days V. by
6 Wound infection Patch rupture 7 weeks V. by
7 Wound infection False aneurysm 9 weeks V. pa
8 None Sinus 6 months V. by
9 None Sinus 9 months V. by
10 None Sinus 11 months V. by
11 None False aneurysm 12 months V. pa
12 None Sinus 13 months V. by
13 None Sinus 18 months Ligat
14 None Sinus 18 months V. by
15 None Patch rupture 23 months V. by
16 None Sinus 24 months V. by
17 None False aneurysm 35 months V. by
18 Haematoma e evacuated Sinus 37 months V. by
19 None Sinus 41 months Ligat
20 Wound infection Abscess 45 months V. by
21 None False aneurysm 81 months V. by
22 None False aneurysm 164 months Caroinfection. In addition, ﬁve other patients who underwent their
primary CEA elsewhere were referred and treated for prosthetic
patch infection at the Inﬁrmary, giving a total of 22 patients in the
series. Table 1 outlines their presentation and management. Six
presented within 60 days of surgery, all of whom had suffered early
wound complications after the primary operation (5 superﬁcial
wound infections, 1 deep wound abscess). Systemic antibiotics
were started immediately upon presentation andwere then revised
based upon cultures andmicrobiology advice. Three patients (Cases
4, 6, & 15) presented with early patch rupture and massive hae-
morrhage and were taken immediately to theatre without further
investigation. All other patients underwent urgent Duplex scanning
to exclude/conﬁrm a false aneurysm as well as establish the
patency of the common, internal and external carotid arteries.
The commonest infecting organismwas Staphylococcus (n¼ 11),
including 4 cases ofMRSA. There have been no cases of MRSA patch
infection since 2004. In addition there were 3 coliform and 2
pseudomonas infections. The choice of redo-operation depended
upon i) bacteriology; ii) the effect of carotid clamping on MCA
velocity at the original procedure; iii) patency of the ICA; and iv)
ease of distal access. The majority underwent debridement and
patch excision, plus secondary reconstruction with either a vein
patch (n ¼ 3) or reversed saphenous vein bypass (n ¼ 14). Three
patients underwent debridement and patch excision plus carotid
ligation. The latter patients had pre-operative Duplex ultrasound
evidence of ICA occlusion and TCD evidence that the ECA did not
signiﬁcantly contribute to collateral ﬂow. Two of the patients with
ICA occlusion had MRSA infection.47 One patient with an abscess
culturing b-haemolytic Streptococcus was treated with debride-
ment, on-table rifampicin irrigation, and post-operative benzyl-
penicillin irrigation because the original operation had involved
a quite high distal ICA dissection. The remaining patient presented
with a rapidly expanding false aneurysm, 14 years following his
original operation. He had been treated elsewhere with a ruptured
abdominal aortic aneurysm 12 months prior to presentation and
intravenous jugular lines had been inserted on the side of the neck
which subsequently developed a patch false aneurysm. It was
assumed (though never microbiologically proven) that this prob-
ably represented a patch infection. Due to co-morbidities (the
patient was now on home oxygen), this was treated by insertion of
a covered stent and 6 weeks of oral antibiotic cover (Fig. 2).ary management Culture Follow-up (months) Reinfection
ion MRSA 133 (Died) No
tch Coliforms 12 No
biotic irrigation b-haemolytic Strep 180 No
pass Pseudomonas 79 (Died) No
pass Coag neg Staph 76 No
pass MRSA 51 (Died) No
tch Staph aureus 170 (Died) No
pass MRSA 39 (Died) No
pass No growth 111 No
pass No growth 5 No
tch No growth 2.5 No
pass Coag neg Staph 16 (Died) No
ion Coliforms/MRSA 96 (Died) No
pass Coliforms 54 No
pass Coag neg Staph 23 (Died) No
pass Pseudomonas 53 No
pass Coag neg Staph 47 No
pass Coag neg Staph 139 No
ion Coag neg Staph 125 No
pass No growth 102 No
pass No growth 36 No
tid stent No cultures 29 No
Figure 2. (a) Rapidly expanding false aneurysm 14 years after CEA. The patient had undergone repair of a ruptured AAA 12 months prior to presenting with the patch infection and
had had emergency jugular lines inserted on the side of the patched CEA. It was assumed, though never proven, that this represented a patch infection. (b) False aneurysm excluded
after insertion of a covered stent. Six weeks post-operatively, the stent was normal on duplex imaging. At three months, it had occluded (without symptoms).
Table 2
Timing andmode of presentation of 123 patients treated for prosthetic carotid patch
infections.
Timing of prosthetic patch infection after CEA
<2 months 2e6 months >6 months
Presentation
Wound infection/abscess 20 1 12
Patch rupture 6 1 6
False aneurysm 3 2 22
Sinus discharge 6 3 28a
Sinus þ false aneurysm 0 2 6
TIA/Stroke 1b 0 1b
Swelling 0 0 3c
Total 36 9 78
a 2 presented with TIA/Stroke as well.
b Paper did not specify any other presentation but reported positive blood
cultures.
c All three cases from Knight et al.10
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No patient was lost to follow-up (median 54 months; range
2.5e180). Therewere no peri-operative deaths. Therewas one post-
operative stroke, giving a 30-day death/stroke rate of 4.5%. This
patient (Case 6) presented with acute patch rupture and massive
haemorrhage secondary to MRSA infection 7 weeks following
surgery. At the original operation, dissection extended high into the
neck (making control of the distal ICA extremely difﬁcult following
patch rupture) and he was noted to have very low MCA velocities
(6 cm/s) during clamping, at the primary operation indicating that
carotid ligation would not be tolerated. He therefore underwent
a reversed saphenous vein bypass following fracture of the styloid
process to facilitate distal access. Unfortunately he developed
a dense hemiparesis following recovery from anaesthesia,
presumably due to cerebral ischaemia during attempts to secure
distal vascular access and shunt insertion. He did, however, recover
signiﬁcantly over the following 6 months and returned to inde-
pendent living.
Nine patients (41%) suffered cranial nerve injuries, four per-
sisting at 30 days. All patients have been followed up with clinical
and Duplex ultrasound surveillance. During the course of follow-
up, no patient has suffered a stroke or developed reinfection.
Eight patients have died, but none as a consequence of stroke or
reinfection. The patient in whom a covered stent was inserted was
found to have occluded his stent (without symptoms) at 3 months
(Fig. 2). The Duplex ultrasound scan at 6 weeks following stent
insertion was normal.
Systematic review
Including the 22 patients from the current series, 123 prosthetic
patch infections have been reported between 1962 and 2012.10e38
Table 2 outlines the mode of presentation relative to the delay
from CEA to onset of infection, while Table 3 reports how many of
the patch infection patients reported early wound complications.
After their primary operation. Thirty-six patients (29%) presented
<2 months (usually reporting peri-operative wound complica-
tions) with infection/abscess and patch rupture predominating.Seventy eight patients (63%) presented after more than 6 months
had elapsed, with chronic sinus and false aneurysms being the
most common presentation. Interestingly, it was quite rare to ﬁnd
a history of post-operativewound infection or haematoma after the
original operation in patients who presented late with their patch
infection. Only two patients in the systematic review presented
with ipsilateral stroke or TIA and there have been only 13 cases of
acute patch rupture in the world literature.
Eighty-seven of 112 patients (78%) in whom the bacteriological
results were reported in the constituent papers reported a positive
culture. Of these positive cultures, 79 (91%) yielded Staphylococci or
Streptococci, including 11 MRSA infections. The remaining isolates
were enterobacter (n ¼ 4), pseudomonas (n ¼ 3), bacteroides
(n¼ 3), coliforms (n ¼ 3), proteus (n¼ 2), enterococcus (n ¼ 1), and
corynebacterium (n ¼ 1).
Table 4 summarises the treatment strategies in the 123 patients
in the systematic review. Most authors advocated patch excision
(94/123 patients, (76%)), with the main debate being the optimal
mode of revascularisation. Seventy-four were treated by debride-
ment, patch excision and autologous reconstruction with either;
Table 3
Relationship between peri-operative wound complications and timing of prosthetic
patch infection.
Timing of prosthetic patch infection after CEA
<2 months 2e6 months >6 months
Wound infection 19 3 1
Haematoma 7 0 2
Nothing 5 4 36
No data provided 5 2 39
Total 36 9 78
C.D. Mann et al. / European Journal of Vascular and Endovascular Surgery 44 (2012) 20e2624vein bypass (n ¼ 37), vein patch (n ¼ 30), arterial bypass (n ¼ 5), or
primary closure (n ¼ 2). Six of these patients suffered peri-
operative strokes, (two fatal) giving a 30-day death/stroke rate of
8.1%. Four survivors undergoing autologous reconstruction devel-
oped reinfection <60 days requiring further debridement and
autologous venous reconstruction. After 60 days, no patient treated
by autologous reconstruction developed a late reinfection.
Seven patients underwent debridement, patch excision and
carotid ligation. One suffered a peri-operative stroke, but there
were no cases of reinfection. Ten patients underwent prosthetic
reconstruction following debridement and patch excision. Of these
7/9 (78%) either died in the peri-operative period or developed
reinfection within 24 months.
In 29 patients (23.6%), the prosthetic patch was left in-situ.
Twenty-three underwent debridement plus; abscess drainage
(n ¼ 14); muscle ﬂap coverage (n ¼ 5), or post-operative antibiotic
irrigation (n ¼ 1). In this heterogenous group of patients, there was
one peri-operative stroke (4.3%), while three developed late rein-
fection (13%). One patient was treated with antibiotics alone, and
was infection free at 24months. An important subgroup are the ﬁve
patients who were treated by insertion of a covered stent. To date,
none who were treated by covered stent insertion have died or
suffered a peri-operative stroke and none have developed
a secondary infection of the stent (median follow-up 12 months).
The Leicester patient occluded his covered stent at 3 months.
Overall infection-free survival is shown in Fig. 3a, with a 10-year
infection-free survival rate of 78%. Fig. 3b compares cumulative
infection-free survival in patients treated by patch excision and
autologous reconstruction (patch, bypass, primary closure, ligation)
compared with all other management strategies. The 10-yearTable 4
Review of management strategies and outcome of 123 patients treated for prosthetic ca
Procedure N¼ 30d
death
30d
stroke
30d D/S Reinfection
in survivors
(months)
Debridement plus
Post-op antibiotics 3 0 0 0 77
Post-op antibiotic irrigation 1 0 0 0
Muscle ﬂap 5 0 1 1
Abscess drainage 14 0 0 0 2,3
No debridement plus
Systemic/oral antibiotics 1 0 0 0
Covered stent 5 0 0 0
Debridement þ patch excision þ
Carotid ligation 7 0 1 1
Vein patch 30 1 3 3 1, 1, 2
Vein bypass 37 1 3 3 1
Prosthetic reconst 10 1 1 1 0.5,2,12,12,16,24
Primary closure 2 0 0 0
Arterial bypass (native) 5 0 0 0
Arterial bypass (allograft) 3 0 0 0
SCM, sternocleidomastoid; PM, pectoralis major.infection-free survival was signiﬁcantly higher (93.5% vs. 47.1%
(p ¼ 0.007)) in patients undergoing autologous reconstruction.Discussion
Despite everyone being aware of prosthetic patch infection
following CEA, only 123 cases have now been reported in the world
literature, suggesting that this complication is grossly under-
reported. The prevalence of patch infection ranges from 0.4 to
1.8%.10e38 The current series (the largest to date) reported a preva-
lence of 0.8% in 2017 patients. Some may view this ﬁgure as being
too high, but there will always be a small risk of infection in any
vascular procedure involving prosthetic material and a prevalence
<1% is similar to the risk of vein patch rupture if the saphenous vein
is harvested from the ankle.48 It is, however, accepted that the vein
rupture risk is less if the groin saphenous vein is used, but that will
limit access to a potentially important autologous conduit in the
future. Alternatives to prosthetic patching include eversion
endarterectomy, bifurcation advancement or perhaps the use of
biological patches. In Leicester, we have now made a decision to
change to bovine pericardial patches (instead of polyester patches)
because of their perceived resistance to infection (virtually no cases
have been reported in the world literature) and because they are
less prone to suture line bleeding. Our Unit routinely administers
dual antiplatelet therapy (regular Aspirin plus 75 mg Clopidogrel
the night before surgery49,50) in order to reduce post-operative
thromboembolic complications, but this practice is associated
with the potential for increasing the risk of neck haematomas (ie
a potential risk factor for patch infection).
The timing of patch infection appears to follow a bimodal
distribution, with one third presenting within two months of the
original procedure (usually with a preceding wound complication),
while two thirds present late (>6 months); usually with chronic
sinuses or pseudoaneurysm formation. Staphylococci and Strepto-
cocciwere the commonest offending pathogens in 90% of cases, and
awareness of this can dictate selection of the optimal choice of
antimicrobial therapy whilst awaiting deﬁnitive cultures.
In most centres, Duplex ultrasound is the ﬁrst-line investigation.
This enables visualisation of patch corrugation (recognised to be
a warning sign of impending patch infection up to a year before
overt clinical presentation41), the presence of deep spacerotid patch infection.
No reinfection in survivors (months) No data (n ¼ )
8,8
180
3,12,24,45
0,1,1,3,16,24,28,44,60,62,72,87
24
3,12,12,32,29
42,96,112,125,133 1
2.5,3,6,6,6,8,12,12,12,12,16,16,
19,20,23,24,24,24,36,42,56,170
2
1,3,4,5,8,11,12,12,12,16,23,24,24,
26,36,39,44,45,47,51,53,54, 56,60,
62,76,79,102,111,139
2
3,12 1
3 1 1 SCM ﬂap
5 3 PM; 1 SCM ﬂaps
3
Figure 3. Infection-free survival following treatment of infected prosthetic carotid
patch. (a) Overall infection-free survival. (b) Infection-free survival in patients treated
with patch excision and autologous reconstruction or ligation (solid line) versus other
methods (dotted line; p ¼ 0.007 log-rank).
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imaging can help with evaluating the upper ICA, ease of access
and help determine whether steps should be taken pre-operatively
to plan an operation that may require access to the skull base.42
Intra-arterial catheter digital subtraction angiography adds little
unless it is a prelude to insertion of a covered stent or coil/
detachable balloon.
The available evidence would suggest that surgical exploration
along with debridement of all infected tissue and patch excision,
combined with revascularisation is probably still the ‘gold stan-
dard’ management strategy for the majority of patients. Options for
autologous reconstruction include vein patch closure or bypass, or
bypass using an autologous arterial conduit (e.g. the superﬁcial
femoral artery36). Whilst concerns have been raised regarding the
potential for catastrophic vein graft rupture in a contaminated
wound, the literature does not to back this up. However, replace-
ment with a prosthetic patch does carry a very high risk reinfection
and should be avoided.14,17,35
Carotid ligation has historically been associated with a high risk
of peri-operative stroke,13 but (in the presence of MRSA infection)may be necessary due to the organism’s virulence.47 In the presence
of a known ICA occlusion on Duplex ultrasound, ligation can be
performed without undue concern. If ligation is to be considered
intra-operatively, the surgeon should already have checked upon
the likely status of the collateral circulation pre-operatively. For
example, those patients who developed neurological symptoms
during carotid clamping under locoregional anaesthesia at the
primary operation will obviously not tolerate ligation. Similarly,
patients with a mean MCA velocity <20 cm/s are also unlikely to
tolerate ligation. In these situations, every attempt should be made
to reconstruct the carotid artery. If necessary, seek expert
assistance.
The systematic review included ﬁve patients who underwent
treatment by insertion of a covered stent. This is an interesting
subgroup as it may prove difﬁcult to be sure that therewas a proven
infection (eg Case 22 in our series). Each of the ﬁve stented cases
had good peri-operative outcomes (Table 4), but it remains to be
seen whether late reinfection becomes a problem. To date, there
has been insufﬁcient follow-up data to address this issue (median
12 months) and it is hoped that centres with longer term experi-
ence of using covered stents to treat prosthetic patch infections will
publish their experience. Because most centres prefer to publish
‘good outcomes’, it may be that the available literature on the role
of covered stents is biased.
In summary, prosthetic patch infection following CEA is a rare,
but under reported complication. In light of the fact that most
authors prefer to publish the ‘best results’, it is highly likely that the
pooledmortality andmorbidity rates in Table 4 represent an under-
estimation of their true value in ‘real world’ practice. Accordingly,
rigorous attention to preventive measures remains paramount. For
now, patch excision and autologous reconstruction remains the
‘gold standard’.
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